Angion Biomedica Prices IPO of 5 Million Shares at $16; to Sell 1.6 Million Shares in Concurrent Private Placement
08:59 AM EST, 02/05/2021 (MT Newswires) -- Angion Biomedica (ANGN), a late-stage biopharmaceutical company, said pre-market Friday that it has priced its initial public offering of 5 million shares at $16, for gross proceeds of $80 million.
The underwriters have also been given a one-month option to buy up to an additional 750,000 shares at the IPO price.
The shares will be listed on the Nasdaq Global Select Market and are set to start trading under the ticker symbol "ANGN" on Friday. The offering is slated to close on Tuesday.
Further, Angion said it has agreed to sell an additional 1.6 million shares in a concurrent private placement at the IPO price of $16 per share to entities affiliated with Vifor International.